on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. has revealed its stake in Mural Oncology plc through a Form 8.3 disclosure. As of July 14, 2025, Vanguard holds 772,659 ordinary shares in Mural Oncology, representing a 4.47% interest. This form submission is under the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.
The disclosure indicates no additional interests or short positions in Mural Oncology beyond these shares. There are no cash-settled or stock-settled derivatives, nor agreements to purchase or sell additional relevant securities.
The only recorded transaction involves a minor sale of 16 shares at USD 2.54 each. No indemnity or options arrangements exist between Vanguard and any other party related to Mural Oncology. Additionally, no Supplemental Form 8 is attached to this disclosure.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news